<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter>Yang X</submitter><pubmed_abstract>As a Traditional Chinese Medicine prescription, Qingjin Yiqi Granules (QJYQ) provides an effective treatment for patients recovering from COVID-19. However, the pharmacokinetics characteristics of the main components of QJYQ &lt;i>in vivo&lt;/i> are still unknown. An efficacious ultra-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was developed and validated for the simultaneous determination of 33 components in rat plasma after oral administration of QJYQ. The plasma samples were precipitated with 400 µL methanol/acetonitrile (1/1, &lt;i>v&lt;/i>/&lt;i>v&lt;/i>) and analyzed in scheduled multiple reaction monitoring mode. The linear relationship of the 33 components was good (r > 0.9928). The lower limit of quantification for 33 components ranged from 0.4-60.5 ng/mL. The average r</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>1155973</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10133546</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Simultaneous determination of multiple components in rat plasma by UHPLC-sMRM for pharmacokinetic studies after oral administration of Qingjin Yiqi Granules.</pubmed_title><pmcid>PMC10133546</pmcid><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Shang Y</pubmed_authors><pubmed_authors>Fang S</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Du K</pubmed_authors><pubmed_authors>Chang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Simultaneous determination of multiple components in rat plasma by UHPLC-sMRM for pharmacokinetic studies after oral administration of Qingjin Yiqi Granules.</name><description>As a Traditional Chinese Medicine prescription, Qingjin Yiqi Granules (QJYQ) provides an effective treatment for patients recovering from COVID-19. However, the pharmacokinetics characteristics of the main components of QJYQ &lt;i>in vivo&lt;/i> are still unknown. An efficacious ultra-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was developed and validated for the simultaneous determination of 33 components in rat plasma after oral administration of QJYQ. The plasma samples were precipitated with 400 µL methanol/acetonitrile (1/1, &lt;i>v&lt;/i>/&lt;i>v&lt;/i>) and analyzed in scheduled multiple reaction monitoring mode. The linear relationship of the 33 components was good (r > 0.9928). The lower limit of quantification for 33 components ranged from 0.4-60.5 ng/mL. The average r</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-05-29T19:43:08.856Z</modification><creation>2025-05-29T19:43:08.856Z</creation></dates><accession>S-EPMC10133546</accession><cross_references><pubmed>37124227</pubmed><doi>10.3389/fphar.2023.1155973</doi></cross_references></HashMap>